EUVIMEDEUVIMED entdecken
Crossref

Euphorbia helioscopia L. exhibits promising therapeutic effects on hemangioendothelioma and melanoma through angiogenesis inhibition

Man Dou, Dongliang Zhu, Guozhen Cui, Haixia Li, Lijun Di, Li Wang

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2024.155666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Man Dou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Faculty of Health Sciences, University of Macau, Macau, PR China; Institute of Translational Medicine, Faculty of …. Hauptthemen laut MEDLINE: Euphorbia, Hemangioendothelioma, Reactive Oxygen Species, Angiogenesis Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: University of Macau Research Services and Knowledge Transfer Office, Fundo para o Desenvolvimento das Ciências e da Tecnologia, Universidade de Macau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Euphorbia helioscopia L (EHL), a widely used medicinal plant in traditional Chinese medicine, has shown promising effects on certain cancers. However, previous studies on EHL did not elucidate the underlying molecular mechanisms. Herein, for the first time, we present the strong therapeutic potential of EHL extracts on malignant hemangioendothelioma, a rare type of vascular tumor. PURPOSE: To investigate the potential anti-tumor mechanism of extracts of EHL on hemangioendothelioma and melanoma. METHODS: The dried stems and leaves of EHL were extracted with Ethyl Acetate and n-Butyl alcohol, yielding two crude extracts Ethyl Acetate fraction (EA) and n-Butyl alcohol fraction (Bu). EA and Bu were prepared to assess the potential mechanism by assays for cell proliferation, cell cycle, apoptosis, colony formation, tube formation, cellular metabolic activity, reactive oxygen species (ROS), N-Acetylcysteine (NAC) antagonism, RNA expression and western blot. To further confirm the anti-tumor effect of EHL in vivo, we established hemangioendothelioma and melanoma tumor-bearing mouse model using node mice and administered with EA and Bu, tracked alterations in tumor volume and survival rate. Furthermore, tissue samples were obtained for histological, protein, and genetic investigations. RESULTS: We demonstrate that the injection of EA and Bu, significantly inhibits tumor growth and prolongs the lifespan of tumor-bearing mice. Bu treatment exhibited a remarkable 33 % healing effect on the primary hemangioendothelioma tumor, bringing the survival rate to a level comparable to that of healthy mice. Mechanically, both EA and Bu impair respiratory chain complexes, leading to mitochondrial dysfunction and accumulation of reactive oxygen species (ROS), resulting in DNA damage, cell apoptosis, and finally blocked angiogenesis. While EA demonstrates robust inhibitory effects on cancer cell growth and a broader impact on metabolism in vitro, the in vivo effect of Bu surpasses that of EA in terms of strength. EA and Bu also exhibit potent anti-tumor effects on a primary melanoma model by inhibiting angiogenesis. Importantly, when compared to other compounds used in the treatment of hemangioendothelioma, EA and Bu demonstrate more profound anti-tumor effects. CONCLUSION: For the first time, our findings reveal that EHL extracts, especially the high polarity compounds, exhibit potent anti-tumor effects by targeting cellular metabolism, specifically through the inhibition of mitochondria-related metabolic activities. This leads to the accumulation of ROS and effectively suppresses abnormal angiogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EuphorbiaHemangioendotheliomaReactive Oxygen SpeciesAngiogenesis InhibitorsApoptosisCell ProliferationPlant ExtractsAntineoplastic Agents, PhytogenicAnimalsHumansMiceCell Line, TumorMelanomaPlant LeavesMelanoma, ExperimentalNeovascularization, PathologicMice, Inbred C57BLMaleAngiogenesis

Stichwörter der Autor:innen

AngiogenesisElectron transport chain complexEuphorbia helioscopia extractsHemangioendotheliomaMitochondrial functionROS

Substanzen

Reactive Oxygen SpeciesAngiogenesis InhibitorsPlant ExtractsAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Biological Sciences, Faculty of Health Sciences, University of Macau, Macau, PR China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, PR China; Ministry of Edu…
  • Bioengineering department, Zunyi Medical college, Zhuhai, Guangdong, Province, PR China.
  • Guang' amen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.

Förderung

  • University of Macau Research Services and Knowledge Transfer Office
  • Fundo para o Desenvolvimento das Ciências e da Tecnologia
  • Universidade de Macau
  • Science and Technology Development Fund
  • National Natural Science Foundation of China

Zitieren

APA

Dou, M., Zhu, D., Cui, G., Li, H., Di, L., & Wang, L. (2024). Euphorbia helioscopia L. exhibits promising therapeutic effects on hemangioendothelioma and melanoma through angiogenesis inhibition. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.155666

Vancouver

Dou M, Zhu D, Cui G, Li H, Di L, Wang L. Euphorbia helioscopia L. exhibits promising therapeutic effects on hemangioendothelioma and melanoma through angiogenesis inhibition. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.155666

BibTeX
@article{Dou2024,
  author = {Dou, Man and Zhu, Dongliang and Cui, Guozhen and Li, Haixia and Di, Lijun and Wang, Li},
  title = {Euphorbia helioscopia L. exhibits promising therapeutic effects on hemangioendothelioma and melanoma through angiogenesis inhibition},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2024.155666}
}
Kostenlos starten →